Allergan PLC (AGN)

AGN (NYSE:Drugs) EQUITY
$216.14
neg -0.10
-0.05%
Today's Range: 215.71 - 217.98 | AGN Avg Daily Volume: 5,288,600
Last Update: 01/13/17 - 4:00 PM EST
Volume: 3,898,459
YTD Performance: 2.92%
Open: $216.00
Previous Close: $216.24
52 Week Range: $184.50 - $301.98
Oustanding Shares: 374,952,199
Market Cap: 81,079,663,512
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 9
Moderate Buy 3 3 3 3
Hold 4 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.62 1.53 1.57 1.57
Latest Dividend: 0.70
Latest Dividend Yield: 1.29%
Dividend Ex-Date: 02/24/17
Price Earnings Ratio: 15.83
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
15.83 6.10 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.98% -24.78% 19.22%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.40 1.60 0.36
Net Income 0.00 -30.20 0.00
EPS 0.00 12.00 1.33
Earnings for AGN:
EBITDA 5.36B
Revenue 15.07B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $3.76 $3.55 $13.40 $16.04
Number of Analysts 9 4 9 12
High Estimate $3.85 $3.60 $13.47 $16.85
Low Estimate $3.71 $3.45 $13.35 $15.57
Prior Year $3.41 $3.04 $13.43 $13.40
Growth Rate (Year over Year) 10.33% 16.69% -0.21% 19.67%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Doug Kass

 | Jan 13, 2017 | 2:17 PM EST
Added to the following longs: ProShares UltraShort S&P500 ETF  (SDS) and Allergan  (AGN) . Added to the following shorts …
RMPIA
By

Doug Kass

 | Jan 12, 2017 | 3:22 PM EST
I have a series of meetings this afternoon and tomorrow morning so I want to get "Takeaways" out early today.
RMPIA
By

Jim Cramer

 | Jan 12, 2017 | 11:28 AM EST
Is the renewed Obamacare debate an opportunity to buy health care stocks?
RMPIA
By

Bret Jensen

 | Jan 12, 2017 | 11:00 AM EST
But the 3% drop in the sector yesterday is clearly an overreaction to Trump's comments.
RMPIA
By

Doug Kass

 | Jan 12, 2017 | 9:41 AM EST
As promised, I am replacing my Allgeran (AGN) that I sold a few days ago at $223 at under $210 now.
RMPIA
By

Jim Cramer

 | Jan 11, 2017 | 2:31 PM EST
He's never really been a stock market guy anyway.
RMPIA
By

Doug Kass

 | Jan 11, 2017 | 11:37 AM EST
As I have written, the risk premium should rise and not decline with the new administration.
RMPIA
By

Doug Kass

 | Jan 10, 2017 | 5:14 PM EST
"I don't feel Tuesday...Tuesday has no feel." --
RMPIA
By

Doug Kass

 | Jan 10, 2017 | 1:12 PM EST
Allergan (AGN) has rallied more than $5 a share from the day's lows to $222.30 at last check after CEO Brent Saunders appeared on CNBC just now.
RMPIA
By

Doug Kass

 | Jan 10, 2017 | 12:43 PM EST
Coming up on CNBC's Fast Money Halftime -- CEO Brent Saunders of Allergan (AGN) .

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.